Acea Bio   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (2002)
Status: Acquired by Sorrento Therapeutics, Inc. (2021)

Organization Overview

First Clinical Trial
2009
NCT01361529
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Acea Bio (Hangzhou) Co., Ltd. | ACEA Therapeutics, Inc. | Hangzhou ACEA Pharmaceutical Research Co., Ltd. | Hangzhou ACEA Pharmaceutical Research Co.,Ltd. | Zhejiang ACEA Pharmaceutical Co. Ltd.